Capital Analysts, LLC Viatris Inc Transaction History
Capital Analysts, LLC
- $2.68 Billion
- Q1 2025
A detailed history of Capital Analysts, LLC transactions in Viatris Inc stock. As of the latest transaction made, Capital Analysts, LLC holds 452 shares of VTRS stock, worth $4,574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
452
Previous 559
19.14%
Holding current value
$4,574
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding VTRS
# of Institutions
1,115Shares Held
946MCall Options Held
4.55MPut Options Held
2.81M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$938 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$754 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$672 Million3.26% of portfolio
-
State Street Corp Boston, MA61.5MShares$622 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...